Orgenesis Inc. (NASDAQ:ORGS – Free Report)’s stock is scheduled to reverse split on the morning of Wednesday, September 25th. The 1-10 reverse split was announced on Monday, September 23rd. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, September 24th.
Orgenesis Stock Down 24.6 %
Shares of NASDAQ:ORGS traded down $0.13 during midday trading on Monday, reaching $0.39. The company’s stock had a trading volume of 757,359 shares, compared to its average volume of 180,954. Orgenesis has a fifty-two week low of $0.25 and a fifty-two week high of $1.08. The firm has a 50 day moving average price of $0.70 and a two-hundred day moving average price of $0.63.
Orgenesis (NASDAQ:ORGS – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.23) earnings per share (EPS) for the quarter. The business had revenue of $0.25 million during the quarter.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Recommended Stories
- Five stocks we like better than Orgenesis
- Where to Find Earnings Call Transcripts
- The Average 401k Balance by Age Explained
- What Makes a Stock a Good Dividend Stock?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Upcoming IPO Stock Lockup Period, Explained
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.